Graft failure is a serious complication of allogeneic hematopoietic stem cell transplantation
(allo-HSCT) defined as either lack of initial engraftment of donor cells (primary graft failure) …

Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

HLA-haploidentical hematopoietic stem cell transplantation is now one of the most
commonly employed alternative donor techniques, with most centers applying T-cell–replete …

ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

Optimal cord blood (CB) unit selection is critical to maximize the likelihood of successful
engraftment and survival after CB transplantation (CBT). However, unit selection can be …

Fanconi anaemia is a challenging disease to manage, and haematopoietic stem-cell
transplantation (HSCT) is the treatment of choice for the haematological complications …

The presence of donor-specific anti-HLA antibodies (DSA) is associated with a 10-fold
increased risk of graft failure in haploidentical stem cell transplantation (haplo-SCT) …

Advances in hematopoietic stem cell transplant (HSCT) have led to changes in the approach
to donor selection. Many of these new approaches result in greater HLA loci mismatching …

The majority of contemporary allogeneic hematopoietic stem cell transplantation (HCT)
procedures utilize partially HLA-mismatched stem cell grafts. Donor-specific anti-HLA …

Donor‐specific anti‐HLA antibodies (DSA) are a major cause of engraftment failure in
patients receiving haploidentical haematopoietic stem cell transplantation (Haplo‐HSCT) …